NEW YORK (GenomeWeb) – SenzaGen announced today that it has signed an agreement under which its GARD skin allergy tests will be marketed worldwide by contract research organization Eurofins BioPharma Product Testing Munich (Eurofins BPT Munich).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.